Volume 22

Issue 1

Article 9

CRUSTACEAN HYPERGLYCEMIC HORMONE: STRUCTURAL VARIANTS,
PHYSIOLOGICAL FUNCTION, AND CELLULAR MECHANISM OF ACTION
Chi-Ying Lee
Department of Biology and Graduate Institute of Biology, National Changhua University of Education, Changhua,
Taiwan, R.O.C., bicylee@cc.ncue.edu.tw

Kuo-Wei Tsai
Department of Biology and Graduate Institute of Biology, National Changhua University of Education, Changhua,
Taiwan, R.O.C.

Wei-Shiun Tsai
Department of Biology and Graduate Institute of Biology, National Changhua University of Education, Changhua,
Taiwan, R.O.C.

Jia-Ying Jiang,
Department of Biology and Graduate Institute of Biology, National Changhua University of Education, Changhua,
Taiwan, R.O.C.

Yan-Jhou Chen
Department of Biology and Graduate Institute of Biology, National Changhua University of Education, Changhua,
Taiwan, R.O.C.

Follow this and additional works at: https://jmstt.ntou.edu.tw/journal
Part of the Aquaculture and Fisheries Commons, and the Marine Biology Commons

Recommended Citation
Lee, Chi-Ying; Tsai, Kuo-Wei; Tsai, Wei-Shiun; Jiang,, Jia-Ying; and Chen, Yan-Jhou (2014) "CRUSTACEAN
HYPERGLYCEMIC HORMONE: STRUCTURAL VARIANTS, PHYSIOLOGICAL FUNCTION, AND CELLULAR MECHANISM
OF ACTION," Journal of Marine Science and Technology: Vol. 22: Iss. 1, Article 9.
DOI: 10.6119/JMST-013-0308-1
Available at: https://jmstt.ntou.edu.tw/journal/vol22/iss1/9
This Research Article is brought to you for free and open access by Journal of Marine Science and Technology. It has been
accepted for inclusion in Journal of Marine Science and Technology by an authorized editor of Journal of Marine Science and
Technology.

CRUSTACEAN HYPERGLYCEMIC HORMONE: STRUCTURAL VARIANTS,
PHYSIOLOGICAL FUNCTION, AND CELLULAR MECHANISM OF ACTION
Acknowledgements
The authors thank the financial support of the National Science Council through grants NSC
98-2321-B-018-001- MY3 and 101-2311-B-018-001 to C.-Y.L.

This research article is available in Journal of Marine Science and Technology: https://jmstt.ntou.edu.tw/journal/
vol22/iss1/9

Journal of Marine Science and Technology, Vol. 22, No. 1, pp. 75-81 (2014 )
DOI: 10.6119/JMST-013-0308-1

75

CRUSTACEAN HYPERGLYCEMIC
HORMONE: STRUCTURAL VARIANTS,
PHYSIOLOGICAL FUNCTION, AND
CELLULAR MECHANISM OF ACTION
Chi-Ying Lee, Kuo-Wei Tsai, Wei-Shiun Tsai, Jia-Ying Jiang,
and Yan-Jhou Chen

Key words: crustacean hyperglycemic hormone, gene expression,
molecular polymorphism, mechanism of action.

ABSTRACT
Crustacean hyperglycemic hormone (CHH) is a peptide
hormone originally identified in the X-organ/sinus gland (XO/
SG) complex of the eyestalks. It belongs to the CHH family
which also includes molt-inhibiting hormone (MIH), vitellogenesis-inhibiting hormone (VIH), and mandibular organinhibiting hormone (MOIH), and ion transport peptide (ITP).
Multiple molecular variants of CHH are generated by both
post-transcriptional and post-translational mechanisms. In
addition to the XO/SG complex, CHH gene is widely expressed
in many extra-eyestalk tissues. Functionally, available data
indicate that CHH is involved with the regulation of carbohydrate metabolism and stress-induced hyperglycemia. Several other physiological processes, including molting, ion and
water balance, reproduction, and immunity, are likely also
regulated by CHH. The functional role(s) of the alternatively
splice form CHH-like peptide (CHH-L) are different from
those of CHH and remain unknown. Combined results
showed that cyclic guanosine 3’,5’-monophosphate (cGMP)
plays important roles in mediating the effects of CHH on
carbohydrate metabolism. Recent studies of receptor guanylyl
cyclase (rGC) may lead to characterization and identification
of CHH receptor(s). Future efforts are needed to fully understand the functional roles of the different CHH variants; identification of CHH receptor(s) hold the promise of revealing in
greater depth the structure/functional relationships of the
various structural variants.
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Department of Biology and Graduate Institute of Biology, National Changhua
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I. INTRODUCTION
Crustacean hyperglycemic hormone (CHH) is a peptide
hormone originally identified in a crustacean neurosecretory
complex, the X-organ/sinus gland complex (XO/SG complex),
located within the eyestalks of decapod crustaceans [16, 60].
Historically, biological significance of the eyestalk XO/SG
complex had been inferred by ablation-replacement experiments that suggested the presence of several hormonal factors.
These included hyperglycemic hormone, gonad-inhibiting
hormone, gonad-stimulating hormone, molt-inhibiting hormone, chromatotrophic hormones, etc. [39, 40]. The wide array
of physiological processes that appear to be under the hormonal control of the eyestalk factors underscores the importance
of the XO/SG complex; it has also spawned ever since research
interests in understanding the molecular, biochemical, and physiological aspects of these peptide hormones [see 16, 42].
Earlier biochemical and physiological studies [e.g., 7, 29,
30, 35, 41, 52, 62, 65, 78], soon followed by a surge of research effort in molecular cloning of the encoding genes [see
4, 20], have established that CHH, being a prototypical member, belong to a family of polypeptide hormones, the CHH
family [34, 36, 60]. The family also includes molt-inhibiting
hormone (MIH), vitellogenesis-inhibiting hormone (VIH), and
mandibular organ-inhibiting hormone (MOIH), and insect ion
transport peptide (ITP) [10, 20, 36]. Recent studies have expanded the existence of the CHH family peptides beyond
arthropods to ecdysozoans [11, 48].
This paper summaries studies of CHH and CHH-related
peptides of decapod crustaceans, including aspects relating to
structure of CHH peptide and gene, spatial pattern of CHH
gene expression, physiological roles, and cellular mechanism
of actions.

II. STRUCTURE OF CHH PEPTIDE AND GENE
Molecular characterizations of CHH precursors indicated
that the precursor consists of a signal peptide, a CHH
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Fig. 1. Multiple alignments of decapod CHH and CHH-L precursor sequences. Conserved cysteine residues characteristic of CHH family peptides are
indicated by an asterisk (*). CPRP: crustacean hyperglycemic hormone precursor-related peptide. CHH sequences are from the following
sources, Sco-CHH: Scylla olivacea, AY372181 [69]; Cam-SG-CHH: Carcinus maenas, X17596 [74]; Hoa-CHH: Homarus americanus, S76846
[18]; Prc-CHH: Procambarus clarkii, AB027291 [78]; Mar-CHH: Macrobrachium rosenbergii, AF219382 [9]; Pej-SGP-I: Marsupenaeus japonicus, AB007507. CHH-L sequences are from the following sources, Sco-CHH-L: S. olivacea, EF530127 [69]; Cam-PO-CHH: C. maenas,
AF286084 [21]; Prc-TG-CHH: P. clarkii, AF474408; Mar-CHH-L: M. rosenbergii, AF372657 [9].

precursor-related peptide (CPRP), and a mature CHH peptide.
Based on this and other sequence characteristics, it was proposed that CHH peptides to be categorized as members of the
type I subgroup of the CHH family (Fig. 1), whereas MIH,
VIH/GIH, and MOIH (the precursors of which lack CPRP) as
members of the type II subgroup of the CHH family [10, 20,
43]. A third subgroup, Type III subgroup, containing insect,
collembolan, and branchiopod ITPs, was later created based
on phylogenetic analysis of pancrustacean CHH family peptides [48].
Multiple CHH variants presumably encoded by separate
genes were reported mainly for astacideans and penaeids.
Thus, there are two CHH variants for Homarus americanus
and Cherax destructor [3, 67], five for Penaeus monodon [17],
and six for P. japonicus [38, 77] that are different to varying
extent in the primary sequences. Direct evidence showing the
presence of multiple CHH genes is provided by studies of
Metapenaeus ensis [26, 27]. In M. ensis, there are at least 6
copies of CHH-A genes that share 98-100% of the encoded
amino acid sequence identity [26], and 2 copies of identical
CHH-B genes [27]. Genomic analysis revealed that most
CHH genes are characterized by containing 4 exons and 3
introns, excepting CHH genes of M. ensis, which like other
type II peptide genes, contain 3 exons and 2 introns [10].
A CHH-like variant was initially purified from the pericardial organ (PO) of Carcinus maenas [21]. This novel
CHH-like peptide (CHH-L) and the sinus gland-derived CHH
share an identical N-terminal sequence (residues 1-40), but
differ considerably in the remaining sequence; they are alternatively spliced products [21]. CHH/CHH-L variants showing
similar differences in sequence characteristics have recently

been reported in Macrobrachium rosenbergii, Pachygrapsus
marmoratus, Potamon ibericum, Scylla olivacea, and Procambarus clarkii [5, 9, 15, 68, 69, 75]; the native peptides
have been purified and characterized for C. maenas, S. olivacea, and P. clarkii [5, 21, 75].
CHH and CHH-L undergo post-translational modifications.
Both peptides contain 3 disulfide bonds formed by 6 highly
conserved cysteine residues [5, 21], which is a distinguishing
feature of the family members. In addition, the N-terminal end
of both peptides is pyroglutamated, whereas C-terminal amidation only occurs in CHH [5, 21]. While N-terminal pyroglutamination appears not necessary for the hyperglycemic
activity of CHH [13], C-terminal amidation significantly affects its biological activity [5, 33, 49].
Structural comparison of the crab (S. olivacea) native CHH
and CHH-L shows that the 2 peptides have similar spectral
profiles of circular dichroism and thermo-stability, indicating
they are composed mainly of α-helices (41% and 36%, respectively) and have a very similar melting temperature at
around 75°C [5]. No experimentally resolved structure has
been reported for any CHH peptides. Three-dimensional
structure for brachyuran CHH and CHH-L were modeled
using Pej-MIH [32] as the template structure. Though still
need experimental verification, the modeled structures for
CHH and CHH-L revealed that they are sterically folded in
similar manners (the root mean square deviation is 0.43), with
each modeled structure contains an N-terminal tail region and
4 α-helices (Fig. 2), consistent with the data of a similarly
modeled structure of P. japonicus CHH [32], and in general
with data showing that CHH and CHH-L have the same disulfide bond pattern [5, 21]. These data suggested that, despite
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Fig. 2. Ribbon model of CHH and CHH-L. Three-dimensional structure of CHH and CHH-L was modeled using the SWISS model server with
Pej-MIH structure as the template structure. Modeled structure of the mud crab (Scylla olivecea) (a) CHH or (b) CHH-L is composed of an
N-terminal tail region and 4 α-helices (green: helix 1, yellow: α-helix 2, blue: α-helix 3, red: α-helix 4). Residues located in corresponding
positions of CHH and CHH-L but with side chains of different properties are indicated by 3-letter code with superscript number showing
residue number; only side chains of these residues are depicted.

significant sequence variations in the C-terminus, CHH and
CHH-L are much similar to structure at higher level [5].
A rare type of post-translation modification occurs in CHH
[63]. CHH variants differing from each other in the stereo
configuration of the third residue (a phenylalanine) were isolated from the sinus glands of various astacideans [2, 3, 61, 65,
77]. It was proposed that D-Phe3 CHH, which contains a
D-phenylalanyl residue at the third position, is derived from
the all-L CHH by the action of putative peptide isomerase in a
late step during the maturation process of the prohormone [54,
64]. On the other hand, CHH-L peptide appears not being
subjected to the L-to-D isomerization. In P. clarkii, a CHH-L
was present in the thoracic ganglia; immunoblotting analysis
of the tissue extracts using an antibody specific for D-Phe3CHH did not detect any immunoreactive protein [75], despite
the fact that the sequences of the first 40 residues from the
N-terminus of CHH and CHH-L are identical. It is suggested
that the putative isomerase activity involved in the posttranslational L-to-D conversion of CHH [54, 64] is absent in
the thoracic ganglia [75].

III. SPATIAL PATTERN OF GENE
EXPRESSION
The presence of CHH peptides in the extra-eyestalk tissues
was proposed more than a decade ago [6, 18]. Subsequently, it
was found that a CHH identical to that originally found in the
XO/SG complex is also expressed in the gut of C. maenas [12].
As stated above, extra-eyestalk tissues (the pericardial organ
and thoracic ganglia) expressed CHH-L peptides [5, 9, 21, 68,
69, 75]. The consensus appears to be that at the protein level
the eyestalks predominantly express CHH, whereas the extraeyestalk tissues express CHH-L [5, 21, 69, 75]. However,
reverse transcription-polymerase chain reaction (RT-PCR)
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Fig. 3. Tissues distribution of CHH and CHH-L transcripts. Total RNA
prepared from the tissues as indicated was reverse transcribed
and amplified with specific primers for CHH or CHH-L. Negative
control reaction was performed using water in stead of tissue
cDNA sample as the template.

analysis of tissues transcripts revealed that both CHH and
CHH-L transcripts are widely expressed in tissues [31, 69]. In
P. clarkii, CHH transcript is clearly and equally detectable by
RT-PCR in the eyestalk ganglia, cerebral ganglia, thoracic
ganglia, circumesophageal nerves, abdominal ganglia, muscle, gut, and heart; whereas CHH-L transcript is most predominant in the thoracic ganglia but also detectable in the
eyestalk ganglia, circumesophageal nerves, abdominal ganglia, gut, and heart (Fig. 3). One possibility is that certain
transcripts are probably not translated into proteins or translated into proteins at extremely low levels. Using a sensitive
sandwich type enzyme-linked immunosorbent assay, it has
been shown that indeed, while the CHH is predominantly
present in the sinus gland, it is also detectable though at much
lower levels in the extra-eyestalk tissues [76].

IV. PHYSIOLOGICAL ROLES
A hyperglycemic factor residing in crustacean eyestalks
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was first revealed by Abramowitz et al. [1]. Accumulated
studies indicated that CHH is involved in regulating blood
glucose levels mainly through mobilization of glucose from
glycogen depots, in particular the muscle and hepatopancreas
[56]; it acts on the target tissues promoting glycogenolysis
while inhibiting glycogen synthesis [37, 57]. A recent study
showed that eyestalk ablation significantly increased glycogen synthase (GS) transcript levels and decreased glycogen
phosphorylase (GP) transcript levels in the hepatopancreas of
M. japonicus [51]. CHH-mediated hyperglycemia in response
to various environmental stressors (extreme temperature,
hypoxia, organic and inorganic pollutants, bacterial infection,
etc.) has been demonstrated [6, 15, 23, 47, 55, 72, 80].
It has been recognized that CHH is a pleiotropic hormone.
It was noted that CHH, in addition to MIH, also suppresses
ecdysteroidogenesis by the Y-organs though at a higher dose
than MIH [7, 14, 73, 78]. The physiological significance of
the CHH-suppressed ecdysteroidogenesis especially with regard to molting remains to be ascertained.
Regarding the 2 functions mentioned above, it appears that
CHH and CHH-L are functionally divergent in that CHH has
significant activity in inducing hyperglycemia, suppressing
ecdysteroid synthesis, or both, whereas CHH-L does not have
either activity [5, 21, 53]; functional roles have yet to be determined for any identified CHH-L. It was shown that coinjection of CHH and CHH did not change the pattern of hyperglycemic responses seen in C. maenas injected with CHH
alone. It is therefore unlikely that CHH-L functions as a
negative regulator of CHH [21]. Differential responses to
stress stimuli between CHH and CHH-L transcript levels were
observed in the blue crab Callinectes sapidus [15].
Another physiological role of CHH involves regulation of
ion and water balance. The discharge of the gut-derived CHH
during pre-molt is suggested to be involved in regulating water
and ion uptake, allowing the swelling necessary for successful
ecdysis and the subsequent increase in size during post-molt
[12]. It has also been demonstrated that CHH exerts ionoregulatory actions on the gill by increasing trans-epithelial potential and sodium influx [8, 59, 66]. The molecular entity directly affected by CHH has yet to be identified.
It is worth a note mentioning that data indicate that D-Phe3
CHH appears to be more potent than its all-L counterpart in
inhibition of ecdysteroid release from Y-organs and [78] and
regulation of hemolymph osmolality [59]. Whether the L-to-D
isomerization of CHH represents a post-translational mechanism that increases bioactivity of the hormone requires additional studies.
Other physiological processes that have been proposed to
be regulated by CHH include vitellogenesis [19, 38, 70] and
methyl farnesoate synthesis by the mandibular organ [46].
Notably, it was demonstrated that in vivo injection of recombinant CHH significantly elicited immune responses, increased pathogen clearance ability and survival rate of
pathogen-infected shrimps [71] and that CHH is expressed in
hemocytes [76]. These recent data suggested a role for CHH

in immune regulation.

V. CELLULAR MECHANISM OF ACTION
Previous studies on the cellular mechanism of action of
CHH suggest that cyclic guanosine 3’,5’-monophosphate
(cGMP) plays important roles in mediating the effects of CHH
on carbohydrate metabolism. Cyclic GMP levels in CHH
target tissues are significantly increased shortly after injection
of CHH [58], in vitro incubation of the target tissues with CHH
elevates tissue cGMP levels in a dose- and time-dependent
manner [24, 25, 50, 58], and the increase in intracellular
cGMP precedes an increase in glucose release into incubation
media [58]. The effect of CHH on cGMP levels is potentiated
by phosphodiesterase inhibitors, suggesting that CHH acts
primarily by stimulating GC [24]. Further, CHH stimulates
GC activity in membrane (but not cytosolic) preparations
of muscle (a CHH target tissue), indicating that increase in
cGMP levels in response to CHH is due to the activation of
membrane-bound GC [24].
cDNA encoding crustacean receptor type GCs (rGCs) were
reported from the muscle of the crayfish, P. clarkii, the Y-organ
of blue crab C. sapidus, and the tropical land crab, Gecarcinus
lateralis [44, 45, 79]. Sequence analysis predicts that the encoded proteins contain the signature domains characteristic of
rGCs, including an extracellular ligand-binding domain, a single transmembrane domain, and intracellular kinase-like and
cyclase catalytic domains [44, 45, 79]. The PcGC-M2 transcript is widely expressed in many tissues [45], fitting the profile of the sites of action of CHH, a pleiotropic hormone with a
wide range of target tissues [22, 28].
In summary, accumulated data generated from studies of
CHH-related peptides revealed multiple molecular variants
and sites of expression. More efforts are needed to correlate
the hormone titers in the blood and tissues with the physiological status of the animals and to devise corresponding
bioassays in order to gain a fuller understanding of the functional roles of the different molecular variants. Ultimately,
identification of specific receptor(s) would reveal in greater
depth the structure/functional relationships of the various
structural CHH variants.
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